IFC Investments in Science Based Businesses

"Over the past decade, IFC has invested more than $200 million in life sciences businesses in 21 developing countries worldwide. Supporting a vibrant life sciences industry is an important way to improve access to affordable pharmaceuticals, particularly for diseases associated with poverty in developing countries, including HIV/AIDS, malaria, and tuberculosis." IFC News, April 23, 2008.

View full text ››    Print     Email     Comment     Add content

Contributor: John Daly
Published Date: April 29, 2008